Showing results (1291-1300 of 1,308) with videos related to

Sort By:
Pageof 131
Arthritis & Rheumatology (Hoboken, N.J.)|November 17, 2023
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration NetworkPasoon Hellamand, Marleen G H van de Sande, Lykke M Ørnbjerg, et al.
The Journal of Rheumatology|June 15, 2026
Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaborationJette Heberg, Stylianos Georgiadis, Zohra Ahmadzay, et al.
Rheumatology (Oxford, England)|December 23, 2021
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and responseSara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, et al.
Annals of the Rheumatic Diseases|July 13, 2026
Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countriesBrigitte Michelsen, Christos Polysopoulos, Michael J Nissen, et al.
Joint Bone Spine|April 6, 2024
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatmentLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, et al.
Health Policy (Amsterdam, Netherlands)|April 17, 2025
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subsetSaedis Saevarsdottir, Lilja Stefansdottir, Patrick Sulem, et al.
Antioxidants & Redox Signaling|December 4, 2012
Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosineLars Barregard, Peter Møller, Trine Henriksen, et al.
RMD Open|July 25, 2024
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational studySara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, et al.
Rheumatology (Oxford, England)|July 23, 2024
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitorsPasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, et al.
Pageof 131